O-040 Randomized phase III trial for stage III unresectable nonsmall cell lung (NSCLC) cancer: Induction Chemotherapy (ICT) [vinorelbine (Vr)-cisplatine (P)] followed by conventional radiation (RT) without (arm A) or with daily carboplatin (Cb) (arm B). Final results. Study CRG/BMS/NPC/96 of the French Lung Cancer Study Group FNCLCC and IFCT
2005 ◽
Vol 23
(16_suppl)
◽
pp. 7016-7016
◽
Keyword(s):
2011 ◽
Vol 47
(10)
◽
pp. 1546-1555
◽
Keyword(s):
Keyword(s):
2008 ◽
Vol 26
(15_suppl)
◽
pp. 7541-7541
◽
Keyword(s):
Keyword(s):
Keyword(s):
2000 ◽
Vol 36
(1)
◽
pp. 3-8
◽
Keyword(s):